Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects
Clinical trial NCT02663687 · COMPLETED
Trial details
- NCT number
- NCT02663687
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-19
- Primary completion
- 2016-12-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.